Safe Harbor Provision for Genetic Tests in Patent Bill Amendment May Be Scrapped | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A measure in the House of Representatives that would create a safe harbor from patent infringement for some genetic tests used to confirm an initial diagnosis, but not provided by the patent holder, may soon be scrapped in favor of a study of the issue by the US Patent and Trademark Office.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.

Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.

MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.

Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.